Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerLeonard B. Saltz, Langdon L. Miller, John V. Cox et al.|New England Journal of Medicine|2000Cited by 3k
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumabDavid R. Gandara, David S. Shames, Achim Rittmeyer et al.|Nature Medicine|2018Cited by 1.2k
Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE StudyHoward S. Höchster, Eric Hedrick, Lowell L. Hart et al.|Journal of Clinical Oncology|2008Cited by 623